MASLD prevalence, incidence and global aspects - PubMed
3 hours ago
- #Global Burden
- #MASLD
- #Prevalence
- Obesity and type 2 diabetes are key factors in the development and outcomes of Metabolic dysfunction-associated steatotic liver disease (MASLD).
- The global burden of MASLD includes its prevalence, incidence, disability from complications, and reduced life expectancy.
- Variability in MASLD prevalence is notable, especially in sub-Saharan Africa and Asia Pacific regions undergoing rapid epidemiological transitions.
- Social determinants of health, such as socioeconomic conditions and systemic discrimination, impact MASLD prevention, diagnosis, and treatment.
- There are opportunities to advance equity in MASLD care worldwide.